Rheumatology A viscosupplementation that lubricates and protects the knee in Pts with osteoarthritis. See Osteoarthritis.
Mentioned in ?
References in periodicals archive ?
Products of viscosupplementation market covered in this research include Adant, Arthrum, Curavisc, Durolane, Euflexxa, Fermathron, Gel-One, Go-On, Hyalgan, Hyalubrix and HyalOne, Jonexa, NeoVisc, Orthovisc and Monovisc, Ostenil, Recosyn, RenehaVis, Supartz/ARTZ, Suplasyn, Suvenyl, Synocrom, Synolis V-A, Synovial, Synvisc and Synvisc-One, Gel-Syn (IBSA Institut Biochimique S.
But he has undergone a series of Synvisc injections into the knee - providing critical, artificial padding in the joint.
Francona said Lowell had an injection of Synvisc, a gel-like substance that sometimes provides relief for inflamed joints.
has announced that preliminary results from a new study indicate that patients using Synvisc (hylan G-F 20) through a single-dose regimen achieved a statistically significant improvement in pain from osteoarthritis of the knee over 26 weeks compared with those using placebo.
Approval of a new label will provide opportunity to broaden the use of Synvisc beyond its current European-approved use in the knee and hip to the two additional joints.
Euflexxa was no worse than Synvisc for treating patients with osteoarthritis of the knee, results from a German study demonstrated.
The jelly-like substance that you have heard about is probably Synvisc from Wyeth Pharmaceuticals.
The Croatian international had Synvisc oil injected into his knee on Thursday and will continue with the treatment for the next three weeks.
But Prso has begun a course of treatment which involves an injection of the oil Synvisc into his knee and insists he will have no problem playing for Rangers throughout the remainder of his contract, which is set to expire in the summer of 2007.
If pain continues, see your doctor for treatment options that range from analgesics such as acetaminophen to traditional anti-inflammatory drugs to newer pill-free relief such as Synvisc, a fluid similar to synovial fluid that is injected into the knee by a physician.
Synvisc was developed using larger molecular weight hylans, and requires fewer injections than earlier products.
In clinical trials, injection of Synvisc once weekly for 3 weeks or Hyalgan once weekly for 5 weeks resulted in pain relief and functional improvement lasting 6 months or more.